AI
Wednesday, June 23, 2010 1:42:29 PM
ARNA: the competitor of VVUS at the next Diabetes Conference…today’s big gainer:
“SAN DIEGO, June 17, 2010 -- /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq:ARNA - News) announced today that new data analyses from lorcaserin's pivotal Phase 3 clinical trial program will be presented in poster sessions at the American Diabetes Association's 70th Scientific Sessions in Orlando, Florida. The two posters will be displayed in the Poster Hall from June 26, 2010, at 10:00 a.m. Eastern Time (ET) until June 28, 2010, at 4:00 p.m. ET.”
6 million shares vol in the morning…but now vol is close to zero (?!).
Jul 4 calls @ 0.15
“SAN DIEGO, June 17, 2010 -- /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq:ARNA - News) announced today that new data analyses from lorcaserin's pivotal Phase 3 clinical trial program will be presented in poster sessions at the American Diabetes Association's 70th Scientific Sessions in Orlando, Florida. The two posters will be displayed in the Poster Hall from June 26, 2010, at 10:00 a.m. Eastern Time (ET) until June 28, 2010, at 4:00 p.m. ET.”
6 million shares vol in the morning…but now vol is close to zero (?!).
Jul 4 calls @ 0.15
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
